Advances in activatable organic photosensitizers for photodynamic therapy are reviewed, highlighting novel synthetic methodologies, their integration into bioconjugates, and their potential in antimicrobial and anticancer treatments, addressing off-target toxicity and enhancing targeted ablation of pathogenic cells.
- Eleni Nestoros
- Amit Sharma
- Marc Vendrell